Long-term Renal Outcomes in Patients With Primary Aldosteronism
Top Cited Papers
Open Access
- 14 June 2006
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 295 (22) , 2638-2645
- https://doi.org/10.1001/jama.295.22.2638
Abstract
Primary aldosteronism is a form of endocrine hypertension characterized by high blood pressure, hypokalemia, suppressed plasma renin activity, and inappropriate aldosterone secretion. Recent studies have reported a greater frequency of primary aldosteronism among patients with hypertension than the previously accepted prevalence of approximately 1%.1,2 Such increased frequency may be the result of more effective identification of this condition due to widespread use of the aldosterone-renin ratio as a screening test.3 Although primary aldosteronism is considered correctable with either removal of an adrenal adenoma or administration of mineralocorticoid receptor antagonists, in many cases, hypertension may persist after treatment.4Keywords
This publication has 0 references indexed in Scilit: